Céline Cano
Impact in
- Toxicology top 2%
- Oncology top 10%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
Papers in
-
- Cancer therapeutics and mechanisms 9
- DNA Repair Mechanisms 6
- Protein Degradation and Inhibitors 6
-
- Synthesis and Biological Evaluation 6
- Carbohydrate Chemistry and Synthesis 4
- Co-authors
- Ian R. Hardcastle (25 shared papers)Roger J. Griffin (28 shared papers)Bernard T. Golding (28 shared papers)David R. Newell (16 shared papers)Nicola J. Curtin (10 shared papers)Suzannah J. Harnor (9 shared papers)S. Hill (2 shared papers)M.E.M. Noble (7 shared papers)
- Journals
- Organic & Biomolecular Chemistry (8 papers)Journal of Medicinal Chemistry (7 papers)Oncotarget (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Clinical Chemistry (3 papers)
- Partner nations
- United KingdomUnited StatesJapan
In The Last Decade
Céline Cano
53 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 87
- Toxicology 112
- Oncology 358
- Organic Chemistry 367
- Molecular Biology 805
- Cancer Research 85
Countries citing papers authored by Céline Cano
This map shows the geographic impact of Céline Cano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Cano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Cano more than expected).
Fields of papers citing papers by Céline Cano
This network shows the impact of papers produced by Céline Cano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Cano. The network helps show where Céline Cano may publish in the future.
Co-authors
The 25 scholars most cited alongside Céline Cano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 100 | |
| 2 | 2015 | 96 | |
| 3 | 2019 | 77 | |
| 4 | 2008 | 72 | |
| 5 | 2017 | 64 | |
| 6 | 2019 | 64 | |
| 7 | 2007 | 62 | |
| 8 | 2011 | 53 | |
| 9 | 2016 | 47 | |
| 10 | 2018 | 43 | |
| 11 | 2013 | 42 | |
| 12 | 2010 | 35 | |
| 13 | 2023 | 35 | |
| 14 | 2014 | 33 | |
| 15 | 2016 | 30 | |
| 16 | 2010 | 24 | |
| 17 | 2017 | 24 | |
| 18 | 2013 | 21 | |
| 19 | 2013 | 21 | |
| 20 | 2012 | 20 |
About Céline Cano
Céline Cano is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Toxicology and Pharmacology, having authored 54 papers that have together received 1.3k indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (9 papers), Cancer therapeutics and mechanisms (9 papers), DNA Repair Mechanisms (6 papers), Protein Degradation and Inhibitors (6 papers), Synthesis and Biological Evaluation (6 papers), Cancer-related Molecular Pathways (5 papers), Microtubule and mitosis dynamics (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). The work is most often cited by research in Toxicology (112 citations), Oncology (358 citations), Organic Chemistry (367 citations), Molecular Biology (805 citations) and Cancer Research (85 citations). Céline Cano has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Ian R. Hardcastle, Roger J. Griffin, Bernard T. Golding, David R. Newell, Nicola J. Curtin, Suzannah J. Harnor, S. Hill, M.E.M. Noble, Simon H. L. Thomas and Caroline J. Richardson. Their work appears in journals such as Organic & Biomolecular Chemistry, Journal of Medicinal Chemistry, Oncotarget, Bioorganic & Medicinal Chemistry Letters and Clinical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.